On the afternoon of July 9, 2024, the seventh session of the SIAT Industry Investment Butterfly Salon on synthetic bio-manufacturing, co-hosted by the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences (hereinafter referred to as "SIAT") and the Innovation and Entrepreneurship Center of PHBS, and the PHBS-CJBS Global Pitch Competition·2024 Preliminary, were held at SIAT.
A scene of the event
The event featured four projects of synthetic bio-manufacturing:
- PAML Biotechnologies: An innovation platform for biomaterials driven by BT (Biological Technology) and IT (Information Technology).
- Powered Carbon: High value-added utilization technology for CO2 through electrocatalytic synthesis.
- SynBiome: Data-driven microbiome engineering.
- Zhongke Xinfei: Artificial phage treatment for multi-drug resistant bacterial infections.
Zhang Kun delivers an opening remark
During his opening speech, Professor Zhang Kun, Executive Director of the Innovation and Entrepreneurship Center at PHBS, mentioned that both SIAT and the PHBS are committed to promoting technological innovation, enhancing international cooperation, facilitating high-quality development, and cultivating new productive forces. This event represents a friendly collaboration between the PHBS Innovation and Entrepreneurship Competition and the SIAT Industry Investment Salon, as well as a vivid practice of interdisciplinary integration by combining the strengths of both parties.
Ms. Zhang Songlan introduces industrial cooperation and commercialization
Ms. Zhang Songlan, Deputy Director of the Cooperation and Commercialization Office at SIAT, introduced the development status and main characteristics of SIAT, sharing the diversified modes of cooperation with the industry and pathways for commercialization.
Dai Lei shares his views on relevant topics
In his speech and sharing on relevant topics, Mr. Dai Lei, Assistant Director of the Institute of Synthetic Biology at SIAT, mentioned that the Shenzhen Institute of Synthetic Biology (referred to as "Synthetic Institute") has gradually formed an integrated model encompassing "basic research + technical breakthrough + industrialization + science and technology finance + talent support." This model shows initial effectiveness in exploring and fulfilling the entire innovation ecosystem, unlocking the potential of new productive forces in synthetic biology. In the future, the Synthetic Institute will focus on the Key Laboratory of Quantitative Synthetic Biology (Chinese Academy of Sciences) as the source of innovation, the National Bio-manufacturing Industry Innovation Center as the engine for commercialization. Relying on major scientific and technological infrastructure for synthetic biology research, it aims to build an innovation ecosystem for the bio-manufacturing industry, explore new fields and tracks for synthetic biology, develop new momentum and advantages, and promote the high-quality development of China's biomanufacturing industry.
Additionally, this special session on synthetic biology at SIAT invited notable figures from the investment community to serve as judges, including Han Fengjin, General Manager of Shanghai Shifeng Xinhui Ventures; Xu Xiaoyun, Partner with Wisdom Ventures; Sui Fuyang, Manager of SZSE Science and Technology Exchange Center; Zhang Xiaoheng, Executive General Manager with Gree Group Hengqin Financial Investment; Zhao Jun, Managing Director with Haoyue Capital; Xu Junye, Vice President with Danlu Ventures; Xu Yaogang, Investment Director with Danen Venturesl; Zhao Yongfa, Partner with Xinheng Lida; Liang Ziqi, Deputy Director with Qianhai Great Wall Fund; Wang Feng, Vice President with China Merchants Securities Investment; Guo Juhong, Vice President with BGI Co-Win; Yu Jie, Founder of Xiyou Species; Li Muxiu, Investment Manager with IDG Capital; Jiang Dan, Investment Director withShenzhen Qianhai Tianhe Cultural Industry Fund.
During the event, representatives of the four projects took turns presenting their advantages in technological innovation, market application, and business model. The investor judges evaluated the projects based on five dimensions: market conditions, solution, business model, expandability, and team capabilities. They had in-depth discussions on each project, offering valuable advice and guidance for the entrepreneurs.
